Blue Bloods fans will have to wait a little longer for the series’ long-planned spinoff. CBS Studios president David Stapf recently shared in an interview that there are no immediate plans for developing a spinoff, despite the show’s popularity. “We don’t have anything that’s going to be in development soon but it’s a brand, a title and a show that is beloved,” Stapf told Deadline. “We’ve got to get it right, so we’re taking our time and trying to figure it out, okay, what is the next iteration of Blue Bloods?”
Stapf emphasized that the current focus is on celebrating the original series throughout its final season. “We have a whole season to go where we intend to celebrate it all season long as to how good that show is, so there’s still time for us to figure that out,” he added.
In November 2023, CBS Entertainment president Amy Reisenbach and Stapf announced that Blue Bloods would not continue beyond season 14. “Blue Bloods will forever be a beloved part of CBS’ legacy. It ruled Friday nights with unprecedented dominance since its premiere and established itself as a pillar of our winning lineup with an exceptionally devoted fan base,” they said in a joint statement. “We’ll be forever grateful to the legendary Leonard Goldberg for developing this signature series and to the amazing cast led by Tom Selleck, who America embraced as family and watched as welcomed guests at the Reagan dinner table.”
The first half of the final season concluded earlier this year, and the final eight episodes are set to air this fall. In May, series star Tom Selleck expressed his hope that the cancellation might be reversed. “For the past 13 years, it has been an honor and a privilege to work on a show that not only celebrates the men and women who protect and serve in New York City, but also displayed the importance of family,” Selleck told The Hollywood Reporter. “Working alongside these incredible actors, writers, producers, directors, and crew has been a dream come true, and I’m grateful to have been a part of this extraordinary group for over 275 episodes. Thank you to CBS Studios and the CBS network for their steadfast support, and we offer heartfelt gratitude to the fans who gathered with us for dinner every Friday night.”
Despite the show’s end, Paramount Global co-CEO Brian Robbins hinted at a possible return during a shareholders’ meeting last month. “In TV, new franchise extensions are coming for Dexter, Billions, and Blue Bloods,” he said, offering a glimmer of hope for fans.
However, patience will be essential for those anticipating any sort of Blue Bloods spinoff. Robbins’ comments suggested that the long-running family/cop drama might spawn a spinoff, but it was not clear if any such offshoot would be for CBS or Paramount+. The focus right now seems to be on finding the very best premise, especially after one pitch centered on Donnie Wahlberg’s Danny Reagan failed to materialize.
“We don’t have anything that’s going to be in development soon, but it’s a brand, a title and a show that is beloved,” Stapf reiterated. “We’ve got to get it right, so we’re taking our time and trying to figure it out, ‘OK, what is the next iteration of Blue Bloods?’” With the original series’ final eight episodes slated to air this fall through December, Stapf noted, “We have a whole season to go where we intend to celebrate it all season long… so there’s still time for us to figure that out.”
Tom Selleck and other cast members had lobbied for the show to continue, but CBS Entertainment president Amy Reisenbach has remained firm that it’s time for the cop show to turn in its badge. “We love this cast, we love their passion for the show. All shows have to come to an end. It’s important to us to refresh the schedule,” Reisenbach said in May. “We are going to end the show come December.”
As the final episodes approach, fans are left to savor the remaining moments of a series that has become a staple of Friday night television. The legacy of Blue Bloods will undoubtedly continue to resonate with its devoted fan base, even as they await news of a potential spinoff.
Source: Deadline, The Hollywood Reporter
